MYC and cancer: Together, these studies indicate that DDX5 acts as an upstream master regulator to control the expression of survivin, Mcl‐1, XIAP, cIAP2, c‐Myc and mKras, which are key oncogenic proteins involved in cancer development and malignant networks.